| Identification | Back Directory | [Name]
3,5,9-Trioxa-4-phosphapentacos-18-en-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R,18Z)- | [CAS]
76790-27-7 | [Synonyms]
GlycerolImpurity6
3,5,9-Trioxa-4-phosphapentacos-18-en-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R,18Z)- | [Molecular Formula]
C24H48NO7P | [MOL File]
76790-27-7.mol | [Molecular Weight]
493.62 |
| Hazard Information | Back Directory | [Uses]
LysoPC(16:1(9Z)) is a type of lysophosphatidylcholine that can be used to study spleen deficiency syndrome[1]. | [Definition]
ChEBI: 1-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine is a 1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (9Z)-hexadecenoyl (palmitoleoyl). It has a role as a mouse metabolite and a human metabolite. It is a lysophosphatidylcholine 16:1, a 1-O-acyl-sn-glycero-3-phosphocholine and a [(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine. It is functionally related to a palmitoleic acid. | [References]
[1] Yang Xin, et al. Serum Metabonomics Analysis of Fuzi Lizhong Decoction for the Treatment of Splenasthenic Syndrome. Chromatographia.2017; 80(7), 1047–1059. |
|
|